An FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared what the verdict means for the future of mental health care, while doctors stressed supervision.

If approved, MDMA-AT would be the first psychedelic-based therapeutic cleared by the FDA for any condition in the US and the first PTSD medication to receive approval in 24 years.

Over 190 patients, who received doses of MDMA in addition to therapy, showed a significant reduction in PTSD scores compared to placebo. The FDA's staff reviewers on Friday raised concerns that ...

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD. FDA rejects MDMA-assisted therapy for PTSD in a setback for psychedelic medicine.

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...

The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic ...